causal

Insulin Protections Extended Decades Block Generics

All top-selling insulin drugs have extended their protection by at least 20 years, each piling on dozens of protections (one with 55), and these provide the volume positions that set up PBM deals so cheaper generic insulin—even from nonprofits—cannot get into health plan coverage and therefore cannot reach patients, despite insulin being a long-discovered 'magic bullet.'

causalpending

Speaker

Robin Feldman

Evidence Quote

“There are nonprofit organizations that are trying to come up with cheap, generic insulins. But, you can make the drug; if you can't get your way into the health care coverage... no patient is going to get that drug.”

Source

Robin Feldman on Drugs, Money, and Secret Handshakes— EconTalk
Created: 6/13/2026, 12:12:41 AM

Your notes

Loading notes...